gepotidacin,
GSK2140944,
Gepotidacin,
1075236-89-3,
GSK2140944,
GSK-2140944,
UNII-DVF0PR037D,
GSK 2140944,
DVF0PR037D,
3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-((4-(((3,4-dihydro-2H-pyrano(2,3-C)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-, (2R)-,
3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-[[4-[[(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-, (2R)-,
GSK2140944E,
Gepotidacin [USAN:INN],
(3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione,
JHN,
Gepotidacin (USAN/INN),
SCHEMBL3332319,
CHEMBL3317856,
BDBM50050549,
GSK 2140944E,
GSK-2140944E,
AKOS032946511,
CS-6531,
DB12134,
SB16751,
HY-16742,
D10878,
(2R)-2-[(4-{[(3,4-dihydro-2H-pyrano[2,3-c]pyridin- 6-yl)methyl]amino}piperidin-1-yl)methyl]-1,2-dihydro- 3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione,